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Residual Cx45 and its relationship to Cx43
in Murine ventricular myocardium
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Cx40, connexin40; GST, glutathione S-transferase; CaMKII, Ca 2+/calmodulin-dependent protein kinase II; CK1, casein kinase 1;
WT, wild type; Cx45OEs, mice with cardiac-selective overexpression of Cx45; LV, left ventricular; RV, right ventricular; AV, atrioventricular; SA, sino-atrial; PCR, polymerase chain reaction; α-MHC, alpha-myosin heavy chain; fl, floxed; Cx40KICx45/KICx45, Cx40
knockin Cx45 mice; CT, carboxy-terminal; MS, mass spectrometry; SDS, sodium dodecyl sulfate; IB, immunoblotting
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Gap junction channels in ventricular myocardium are required for electrical and metabolic coupling between cardiac
myocytes and for normal cardiac pump function. Although much is known about expression patterns and remodeling
of cardiac connexin (Cx)43, little is known about the less abundant Cx45, which is required for embryonic development
and viability, is downregulated in adult hearts, and is pathophysiologically upregulated in human end-stage heart
failure. We applied quantitative immunoblotting and immunoprecipitation to native myocardial extracts, immunogold
electron microscopy to cardiac tissue and membrane sections, electrophysiological recordings to whole hearts, and
high-resolution tandem mass spectrometry to Cx45 fusion protein, and developed two new tools, anti-Cx45 antisera and
Cre+;Cx45 floxed mice, to facilitate characterization of Cx45 in adult mammalian hearts.
We found that Cx45 represents 0.3% of total Cx protein (predominantly 200 fmol Cx43 protein/μg ventricular protein)
and colocalizes with Cx43 in native ventricular gap junctions, particularly in the apex and septum. Cre+;Cx45 floxed mice
express 85% less Cx45, but do not exhibit overt electrophysiologic abnormalities. Although the basal phosphorylation
status of native Cx45 remains unknown, CaMKII phosphorylates eight Ser/Thr residues in Cx45 in vitro.
Thus, although downregulation of Cx45 does not produce notable deficits in electrical conduction in adult, diseasefree hearts, Cx45 is a target of the multifunctional kinase CaMKII, and the phosphorylation status of Cx45 and the role of
Cx43/Cx45 heteromeric gap junction channels in both normal and diseased hearts merits further investigation.

Introduction
Cardiac myocyte gap junctions are large specialized aggregates of
intercellular channels responsible for cell-to-cell communication.
Their role is essential for propagation of electrical activity that is
required for cardiac function. Cardiac gap junction channels are
formed by connexins, each of which imparts distinct biophysical
properties depending on the connexin subtype.1-4 Three of the five
connexins expressed in cardiac myocytes are found in ventricular
myocardium. Of those three, Cx43 is the predominant connexin
expressed in working ventricular myocytes and is responsible for
electrical propagation throughout the chamber walls.5 The other

two, Cx45 and Cx30.2, are expressed primarily in the cardiac
conduction system; 6,7 however, the human ortholog, Cx31.9, is
not expressed in the human cardiac conduction system.8 Cx40 is
expressed in the atria.9-11 Most recently, Gros et al.12 have shown
that Cx30 is expressed in the mouse sino-atrial (SA) node. Of
note, Cx45 is absolutely required for cardiac development; genetic
ablation of Cx45 is embryonic lethal.13,14 It is the only connexin
protein whose absence during embryonic development is incompatible with life. Nevertheless, it appears that Cx45 may not be at
all necessary for normal cardiac function post-natally.
As stated above, Cx45 is localized at the endocardial surface
of ventricular myocardium15 in a distribution overlapping that of
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Cx40-expressing myocytes of the conduction system. Expression
of Cx45 by adult working ventricular myocytes is limited.13,16 We
have demonstrated that Cx45 is distributed throughout working
ventricular myocardium of both adult murine and adult human
hearts.17,18 Indeed, Cx45 is responsible for cell-to-cell coupling
in Cx43-null myocytes.19 Because the expression level of Cx45
relative to Cx43 is so much smaller, the contribution of Cx45 to
intercellular current flow is thought to be minimal. However, we
have shown that Cx45 is upregulated in human failing hearts,18
and that increased expression of Cx45 enhances susceptibility to
ventricular tachyarrhythmias in vivo.20 Thus, Cx45 may influence electrical and/or metabolic coupling as a result of pathophysiological remodeling of gap junctions such as that observed
after heart failure or myocardial infarction.
Cardiac connexins have been shown to interact and form heteromeric channels in vitro in heterologous expression systems.21-29
Several studies have reported the consistent finding that expression of Cx45 (~29 pS channels) in cells expressing Cx43 (~90 pS
channels) results in a dominant negative effect characterized by
reduced gap junctional conductance and dye transfer.23-25 These
observations suggest that the absolute abundance of different
connexin proteins in gap junction channels and the relative stoichiometry of multiple connexins within each channel in ventricular myocytes are two important determinants of whole cell
junctional conductances.
To date, Cx43/Cx45 heteromeric gap junction channels
have not been identified definitively nor studied systematically
in native ventricular myocytes. Although there is currently no
direct evidence that Cx45/Cx43 heteromeric channels function
in native hearts, the wide spectrum of single channel conductances observed in pairs of isolated cardiac myocytes,30-33 coupled with the multitude of studies demonstrating heteromeric
channel function in in vitro expression systems21-29,34-36 implicate
the presence of Cx43/Cx45 heteromeric channels in the heart.
The purpose of the present study was to determine the absolute level of Cx45 protein relative to Cx43 in native ventricular
myocardium from the adult mouse, and to establish whether
Cx45 plays a role in cardiac conduction properties in non-failing hearts. We have obtained biochemical and ultra-structural
evidence for coexistence of Cx43 and Cx45 in gap junctions of
working ventricular myocytes. In addition, although the level
of Cx45 protein expression was reduced by ~85% in cardiacrestricted Cx45-deficient mice, no defects in cardiac conduction
parameters were observed. Post-translational modification of
Cx45, a potential regulatory mechanism for the expression and
stability of Cx45, was also explored.

Absolute expression levels of Cx45 and Cx43 in native mouse
ventricular myocardium. Quantitative immunoblots were performed by loading different amounts of six His-Cx45 CT and
GST-Cx43 CT fusion proteins along with samples of ventricular homogenates (Fig. 1). The band densities of the ventricular homogenates fell within the linear portion of the standard
curves for the fusion proteins. As expected, Cx43 protein levels
far exceeded those of Cx45. Mean data from 16 hearts (Table 1)
show that ventricular myocardium contained 215 ± 103 fmol of
Cx43/μg protein. Our average protein yield from a larger group
of 24 hearts was 127 ± 16 μg protein/mg wet weight of ventricular tissue, and the ventricles weighed 112 ± 15 mg wet weight
(n = 24). Thus, based on these averages, we observed 27 pmol
Cx43 protein per mg wet weight of tissue, and the ventricles of
each heart expressed 3 nmol of Cx43. Cx45 protein expression
in murine ventricular myocardium, on the other hand, was 0.7
± 0.2 fmol/μg protein, or 10 pmol of Cx45 per heart, or 0.3% of
total ventricular connexin protein levels (Table 1).
Relative expression of Cx45 and Cx43 in ventricular gap
junctions. Despite the relatively low abundance of Cx45 in ventricular myocardium, double label immunoelectron microscopy
of vibratome sections of murine ventricular myocardium demonstrated that Cx45- as well as Cx43-bound colloidal gold particles
were found together in the same gap junction plaques (data not
shown). All subsequent analyses were performed on gap junction-enriched membrane preparations (Fig. 2A). The majority
(87%) of gap junctions isolated from WT hearts was labeled only
with Cx43 (Fig. 2A, left and B). Double label immunoelectron
microscopy of gap junction-enriched membrane fractions using
a pre-embedding staining protocol showed more abundant labeling of Cx43 (96%) than Cx45 (4%) in plaques isolated from the
13% of WT gap junctions that contained both Cx43 and Cx45
(Fig. 2A, right and C). The combined Cx43 signal (87% plus
0.96 of 13%, or 12.5% in heteromeric junctions) of 99.5% is
consistent with the quantitative immunoblot data (99.7%).
Previously, we reported that Cx45OEs exhibit a 2-fold increase
in Cx45 immunoreactive signal and a 25% increase in total Cx45
protein on immunoblots.20 In the present study, we analyzed gap
junction-enriched preparations isolated from WT and Cx45OE
hearts. We found a larger percentage of heteromeric junctions
(55% compared to 13% in wild-type hearts) in preparations isolated from Cx45OE hearts (Fig. 2B). However, the relative stoichiometry of Cx43:Cx45 was comparable in the 55% of Cx45OE
gap junctions that contained both connexins; the relative abundance of Cx43 and Cx45 in gap junctional plaques containing
both Cx43 and Cx45 was ~95:5 in both WT and Cx45OE hearts
(Fig. 2C). Of note, no gap junctions containing Cx45 alone were
found in either genotype. Not surprisingly, there was more Cx45
staining as a percentage of total Cx43 plus Cx45 found in preparations isolated from Cx45OE (4.1%) compared to WT hearts
(1.4%). Finally, the percentage of heteromeric gap junctions
containing both Cx43 and Cx45 was higher in gap junctionenriched membrane preparations isolated from the LV apex plus
septum compared to those isolated from the LV free wall, consistent with more Cx45 expressed in the ventricular conduction
system (Fig. 2D).
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Results
Specificity of the monoclonal antibodies used for the quantitative
immunoblots is shown in Figure 1 and Figure S3. Each antibody
detected its respective CT fusion protein and connexin protein in
ventricular samples, but not the other fusion protein or connexin
in ventricular samples. The anti-Cx43 antibody detected either
GST-Cx43 CT fusion protein (Fig. 1) or thrombin-cleaved Cx43
CT alone (Fig. S3).
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Figure 1. Representative quantitative immunoblots of a membrane probed first with anti-Cx45 antiserum (top), stripped, then reprobed with
anti‑Cx43 antibody (bottom). The gel was loaded with increasing amounts of Cx45 fusion protein (fp, five lanes on the left), ventricular homogenates
from Cx45OE and wild-type (WT) mice (15 μg protein, four lanes in the middle), and increasing amounts of GST-Cx43 fusion protein (fp, five lanes on
the right). The anti-Cx45 antiserum recognized only the Cx45 fusion protein at ~16 kD (top gel, left lanes) and Cx45 in the ventricular homogenates
(top gel, center lanes), but not the Cx43 fusion protein (top gel, right lanes). The anti-Cx43 antibody, on the other hand, recognized only the GST-Cx43
fusion protein at ~43 kD (bottom gel, right lanes) and Cx43 in the ventricular homogenates (bottom gel, center lanes), but not the Cx45 fusion protein
(bottom gel, left lanes).

Co-precipitation of Cx43 and Cx45 from ventricular
myocardium. Ventricular lysates prepared from WT mice were
subjected to immunoprecipitation. Immunoblotting with antiCx45 antibody demonstrated that Cx45 was co-precipitated with
proteins immunoprecipitated with anti-Cx43 antibody (Fig. 3).
In addition, Cx43 was co-precipitated with proteins immunoprecipitated with anti-Cx45 antibody (Fig. 3).
Neither cardiac-restricted reduction nor overexpression of
Cx45 significantly alters electrophysiological properties of the
heart in vitro. Despite the overall low abundance of Cx45 in
adult working ventricular myocytes, it is critical for development
of the heart and vasculature.13,14 Mice with germline ablation of
Cx45 die at embryonic day 10.5. Cx45 is present in the SA node
and conduction system,7,15,46 where it can largely replace Cx40,
producing normal propagation in the atrio-ventricular (AV) node
and left bundle branch and partial loss of function in the right
bundle branch as shown in transgenic mice in which Cx45 was
engineered to replace Cx40.39 The question of whether Cx45
plays any role in conduction has been difficult to assess in the
absence of survival of mice with germline ablation of Cx45, and
in the absence of suitable antibodies directed against Cx45.

www.landesbioscience.com

Table 1. Concentration of Cx43 and Cx45 in ventricular myocardium
Per μg protein
loaded on gel

Per mg wet weight
of tissue

Per heart
(ventricles)

Cx43
(n = 12)

215 ± 103 fmol/μg
protein

27 pmol/mg wet
weight

3 nmol

Cx45
(n = 16)

0.7 ± 0.2 fmol/μg
protein

0.09 pmol/mg wet
weight

10 pmol

Per tissue and per heart values were calculated using the following
average empirical values obtained from 24 hearts: 127 μg protein/mg
wet weight of ventricular tissue and 112 mg wet weight of RV + LV.

In the present study, we created a line of mice with
Cx45‑deficient hearts (Fig. 4) in both our Bonn and St. Louis
laboratories. Mice were not born with the expected Mendelian
inheritance pattern, suggesting either transient embryonic activation of the α-MHC promoter or a survival advantage of perinatal
expression of Cx45 protein. Only 9 Cre +;Cx45fl/fl mice were born
out of 87 pups in 17 litters (Table 2). One mouse died before
weaning; one mouse died after weaning but before it could be
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Figure 2. Immunogold electron microscopy of cardiac connexins in hybrid (heteromeric and/or heterotypic) gap junctions. (A) Electron micrographic
images of gap junctions decorated with 10 nm gold particles conjugated with anti-Cx43 antiserum (left), and a gap junction containing a 20 nm
gold particle conjugated to anti-Cx45 antiserum (inset, arrow) among numerous 10 nm gold particles conjugated to anti-Cx43 antibody (right). Bar
= 100 nm. (B) Proportions of Cx43-bound gold particles and Cx45-bound gold particles as a percent of total gap junctions in gap junction-enriched
membrane preparations isolated from wild-type (WT) and Cx45OE hearts. WT hearts exhibited a larger percentage (87%) of homomeric/homotypic
Cx43 gap junctions. In contrast, the percentages of Cx43 only and heteromeric gap junctions in Cx45OE hearts were roughly equivalent. Cx45
homomeric/homotypic gap junctions were not found in either WT or Cx45OE hearts. (C) The percentage of Cx43 and Cx45 in heteromeric gap
junction channels was comparable in WT and Cx45OE hearts, despite the fact that there was a greater proportion of heteromeric gap junction
channels in Cx45OE hearts. (D) Relative proportions of Cx43 homomeric/homotypic and Cx43/Cx45 heteromeric gap junctions by gross regions of the
hearts. More heteromeric gap junctions were observed in the apex/septum compared to the LV free wall consistent with known expression of Cx45 in
the cardiac conduction system which is concentrated in the subendocardial interventricular septum and in the distal Purkinje system.

Figure 3. Co-immunoprecipitation of Cx43 and Cx45 from murine ventricular myocardium. Cx45 (upper left, lane 5) or Cx43 (upper right, lane 3) were
immunoprecipitated (IP) using mouse monoclonal anti-Cx45 or anti-Cx43 antibodies bound to protein G sepharose beads, respectively. The proteins
in the immunoprecipitates were resolved by SDS-polyacrylamide gel electrophoresis and subjected to immunoblotting (IB) with rabbit polyclonal
anti-Cx43 and anti-Cx45 antibodies to reveal Cx43 (square) in Cx45-associated proteins (lower left, lane 5) and Cx45 (square) in Cx43-associated
proteins (lower right, lane 3). Neither Cx43 nor Cx45 were observed in the negative controls in which mouse IgG1 was bound to protein G sepharose
beads (IgG). In, supernatant of ventricular homogenates (input).

492

Channels

Volume 5 Issue 6

©201
1L
andesBi
os
c
i
enc
e.
Donotdi
s
t
r
i
but
e.

Figure 4. Cardiac-restricted ablation of Cx45 was accomplished by crossing Cx45 floxed mice with α-MHC-Cre+ mice. (A) Agarose gel showing banding
patterns of the PCR products used to genotype cardiac-restricted ablation of Cx45. DNA samples from 6 different mice were run on this gel. Two PCR
reactions were run for each mouse to determine whether they carried the Cre transgene (lanes 1, 3, 5, 7, 9 and 11) and whether they carried two wildtype, a wild-type and a floxed, or two floxed alleles (lanes 2, 4, 6, 8, 10 and 12). The sizes of the bands are as follows: Cx45 wild-type allele, 380 kb; Cx45
floxed allele, 500 kb; Cre transgene, 292 kb. (B) Immunoblot of cardiac Cx45-deficient (Cre+;Cx45fl/fl) whole ventricular homogenates (F; lanes 2, 4 and
6) and controls (C; lanes 1, 3 and 5) showing markedly reduced Cx45 in Cre+;Cx45fl/fl ventricles. Lane 7 shows a strong Cx45 band in atrial homogenate
from Cx40KO/Cx45 knockin (KI) compared to the weaker Cx45 band in wild-type atrial homogenate (WT) shown in lane 8. The membrane was stripped
and reprobed with anti-actin antibodies to show equal protein (20 μg) loading. (C) Histograms show summarized data of the confocal analysis of
ventricular tissue sections stained with anti-Cx45, anti-Cx43 and anti-Cx40 antibodies. Values represent connexin immunoreactive signal as a percent
of total tissue area (mean ± SD). Cx45 was significantly reduced in cardiac Cx45-deficient hearts. *p = 0.016.

studied. Of the seven remaining Cx45 cardiac-deficient mice,
four mice were studied electrophysiologically. Immunoblotting
(n = 6 Cx45-deficient mice) and immunostaining (n = 5 Cx45deficient mice) were performed using a new anti-Cx45 antiserum
whose characterization is described in the Supplemental Material
and Methods. As expected, Cx45 protein expression was reduced
in Cx45-deficient hearts (Fig. 4B). Residual levels of Cx45 were
still present in whole ventricular homogenates prepared from
Cre +;Cx45fl/fl mice. Immunofluorescence images demonstrated an
85% reduction in Cx45 immunoreactive signal in Cx45-deficient
hearts compared to controls (Fig. 5, left parts). Using ImageJ,
we quantified Cx45, Cx43 and Cx40 immunoreactive signal in
ventricular myocardium and found that only Cx45 was reduced
in Cx45-deficient hearts (Fig. 4C). Cx40 signal was analyzed in
the conduction system located in the subendocardial region of
the interventricular septum and was unchanged in cardiac Cx45deficient compared to control hearts (Fig. 4C).
Although cardiac Cx45-deficient mice were not born in the
expected numbers, those that were born did not have any gross
functional defects and survived to adulthood. Two Cre +;Cx45fl/fl
mice gave birth to offspring that themselves grew to adulthood.

www.landesbioscience.com

Their surface ECGs appeared normal (data not shown). QRS
complexes were comparable to those recorded from control mice
(Fig. S4); QRS duration in cardiac Cx45-deficient mice was 11.2
± 1.2 ms (n = 4, p = 0.367) compared to 10.5 ± 1.1 ms in FVB
controls (n = 5). Mean ventricular effective refractory periods
were 110 ms for cardiac Cx45-deficient hearts (n = 2) compared
with 123 ± 19 ms for controls (n = 3). We measured activation
times between the RV apex and the LV lateral free wall to assess
conduction through the specialized conduction system compared
with that through the ventricular myocardium. Conduction
during sinus rhythm is expected to result in nearly simultaneous activation of the right and left ventricles; this was indeed
observed as shown in Table S1; activation of right and left ventricles occurred within 1 ms of each other, both in FVB controls
(0.7 ± 1.2 ms) and in cardiac Cx45-deficient hearts (0.3 ms).
Pacing from the right atrium produced similar activation times
as those observed during sinus rhythm (0.6 ± 0.7 ms in controls
vs. 1.0 ms in cardiac Cx45-deficient hearts). Pacing from the RV
apex produced the expected activation delay through the ventricular myocardium (12.5 ± 2.7 ms); a comparable mean delay
(15.4 ms) was observed in the two cardiac Cx45-deficient hearts.
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Table 2. Cardiac Cx45-deficient mice
No. of litters

Total

Mating

No. of pups born

Actual nulls (% of pups born)

10

Cre ;Cx45

52

13 (25%)

3 (6%)

6

Cre -;Cx45fl/fl x Cre+;Cx45fl/fl

30

15 (50%)

5 (17%)

1

Cre+;Cx45fl/fl x Cre+;Cx45fl/+

17

fl/fl

x Cre ;Cx45

Expected nulls (% of pups born)

fl/+

-

+

5

2.5 (50%)

1 (20%)

87

30.5 (35%)

9 (10%)
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Figure 5. Representative confocal images from a control heart (upper three parts) and a Cre+;Cx45fl/fl heart (lower three parts) showing lack of Cx45
staining in the ventricle of the cardiac-restricted Cx45-deficient heart (lower left part). Adjacent tissue sections were stained for Cx45, Cx43 and
Cx40, and every effort was made to select the same region in each heart for comparison. The ventricular chamber is at the bottom of each field. The
subendocardial conduction system can be seen most clearly in the images stained for Cx40 (right parts). Cx43 and Cx45 are each expressed in this
same region as well as in the ventricular myocardium beyond the subendocardial layer in the control heart (upper middle and left parts, respectively).
Cx43 immunostaining is comparable in the control and Cre+;Cx45fl/fl hearts (upper and lower middle parts, respectively). Bars = 10 μm.

Although the number of mice studied was too low to perform
statistical analyses, these data suggest that ablation of cardiac
Cx45 does not adversely affect cardiac conduction. Isochronal
maps demonstrating conduction in two cardiac Cx45-deficient
hearts also indicate no difference in conduction velocity or patterns compared to those in control hearts; one example is shown
in Figure S5.
Previously, we found that Cx45OEs exhibited increased susceptibility to inducible ventricular arrhythmias compared to
WT littermate controls.20 In the present study, we performed in
vitro electrophysiology studies on perfused hearts. We calculated
conduction velocities from optical action potentials elicited after
S1 stimulation at the RV apex (180 ms cycle length) and after
S2 stimulation at the center of the LV lateral free wall (140 ms
coupling interval) in five Cx45OEs and six WT littermates.
We found no significant differences in conduction velocities
or anisotropic ratios recorded from Cx45OE versus WT hearts
(Table S2). Ventricular activation times measured between the
RV apex and the LV epicardial free wall were not different in
Cx45OE compared to WT hearts (Table S3). Activation times
obtained from these mice (C57BL6) were comparable to those
obtained in mice in the FVB background (Table S1).

494

Because overall conduction velocities were not different in
Cx45OEs, we quantified the spatial inhomogeneity in conduction by calculating an inhomogeneity index in a group of eight
hearts (five wild-types and three Cx45OEs) from optical action
potential data, as reported by Lammers et al.44 We paced each
heart from the right atrium (n = 7) or high right septum (in one
WT heart) at a basic cycle length of 180 ms. Activation times
were obtained from optical action potentials collected from the
LV lateral free wall. A small but significant increase in the inhomogeneity index of Cx45OE hearts was not accompanied by a
difference in the absolute inhomogeneity of ventricular conduction in Cx45OE hearts (Table S4). Additional S1 or S1/S2 pacing
protocols applied to the ventricles did not result in any significant
differences in inhomogeneity indices between Cx45OE and WT
hearts (data not shown). Thus, neither 85% reduction nor 2-fold
overexpression of Cx45 significantly altered electrophysiological
properties of the intact heart in vitro.
High-resolution identification of Ser phosphorylation
sites on the Cx45 CT tail. The mechanism(s) responsible for
controlling Cx45 protein expression levels are not known.
Phosphorylation and/or dephosphorylation of Cx43 have/has
been implicated in turnover of Cx43 after myocardial ischemic
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Figure 6. Sequence of mouse Cx45 (NCBI: X63100). Amino acid residues in black and red bold font indicate the sequence of the C-terminus included
in the six His-Cx45 CT fusion protein analyzed by mass spectrometry. We obtained 89% coverage of this sequence (red). Seven Ser and one Thr
residues (highlighted, red underscored) were phosphorylated by CaMKII in vitro as identified by tandem mass spectrometry. Spectra and tables of
fragmentation ions are given in the Supplemental Content.

injury. Cx45 is known to be a phosphoprotein; 47-49 however, it
has not been studied as extensively as Cx43 with respect to phosphorylation at specific residues in the CT tail or with regard to
specific protein kinases that may phosphorylate Cx45. In the
present study, we subjected the six His-Cx45 CT fusion protein
to phosphorylation by CaMKII and identified seven Ser (S326,
S381, S382, S384, S385, S387, S393) and one Thr (T337) residues by high resolution mass spectrometry with 89% coverage
of the Cx45 CT sequence (Fig. 6) that were targets of CaMKII
in vitro. No phospho-peptides were identified in the negative
control samples. Extracted ion chromatograms, MS1 and MS2
spectra (Figs. S6–S10) and tables of theoretical and observed
peptide fragmentation ions (Tables S5–S9) are included in the
Supplemental Content for each phospho-peptide identified.
Interestingly, five of the seven Ser residues that were phosphorylated by CaMKII were also found to be phosphorylated in vitro
by CK1 (S326, S382, S384, S387, S393) as shown in Figures
S11–S14 and Tables S10–S13.

times more abundant than Cx45 (Table 1). Similar expression
levels of integral membrane proteins have been reported based
on quantitative immunoblot analyses. McDonald et al.50 reported
70–80 fmol Na+ -Ca 2+ exchanger/μg protein in left and right ventricles of guinea pig hearts. Valiunas et al.51 found 100–500 fmol
Cx40 and Cx43/μg protein in HeLa cell transfectants. Recently,
Lin et al.52 reported 400 fmol Cx43/μg protein in ventricular tissue homogenates from neonatal mice.
Changes in Cx45 protein levels do not adversely affect cardiac electrophysiological properties. The absence of measurable
abnormal electrophysiological properties in cardiac Cx45-deficient
and Cx45OE hearts is consistent with low levels of expression of
Cx45 in tissue that has a large reserve of Cx43.53-56 It should be
noted, however, that lack of a measurable defect does not prove
absence of a defect in Cx45 transgenic mice. These studies do not
address whether altered levels of Cx45 contribute to electrophysiological abnormalities in diseased hearts or in those in which acute
or chronic remodeling of Cx43 may have occurred due to aging,
injury or other metabolic changes. In addition, closer examination
of regions of the heart known to express Cx45 may reveal subtle
functional differences when Cx45 is downregulated. For example,
there are regions of the AV node in which Cx43 is significantly
reduced or absent.57,58 Presumably, impulses propagate through
Cx45 gap junction channels in this part of the AV junction and
could be altered if expression of Cx45 is reduced. Similarly, regions
of the SA node have been reported to express Cx45 alone (no
Cx40 or Cx43),46 but both Cx30.2 and Cx30 are expressed in the
SA node6,12 and may explain why we saw no sinus alterations in
Cx45floxed mice. Finally, one area of interest that deserves greater
scrutiny is the Purkinje system and Purkinje-myocyte junction.
Recently, several elegant studies have highlighted the importance
of the distal conduction system in triggering ventricular arrhythmias.59 Our studies did not allow us to quantify properties of the
distal conduction system at high enough resolution to rule out
any defects in Purkinje fibers or their coupling with ventricular
myocytes in Cx45-deficient hearts.
Post-translational modification of Cx45 by CaMKII. Our
data demonstrating the existence of heteromeric gap junction
channels in native ventricular myocardium combined with the
observation that the ratio of Cx43:Cx45 not only regulates gap
junctional intercellular communication,23-25,34-36 but gap junction
size itself,17,60 suggest that the number and size of gap junctions in
Cx45 transgenic hearts may be altered. The mechanisms underlying
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Residual Cx45 protein levels and heteromeric gap junctions in
ventricular myocardium. Several studies have demonstrated that
Cx45 is expressed in working ventricular myocardium and isolated
myocytes.13,16-19 Although its protein level in normal, disease-free
hearts is very low, the absolute amount of its protein expression
had not been established. Furthermore, ultrastructural and biochemical evidence of Cx43/Cx45 heteromeric gap junctions in
native ventricular myocardium was lacking. In the present study,
we have obtained evidence from immunogold electron microscopy as well as co-immunoprecipitation studies that supports the
co-existence of Cx43 and Cx45 in native murine ventricular gap
junctions. We used these two complementary approaches to demonstrate presence of both Cx43 and Cx45 in cardiac gap junctions. Immunogold labeling identified both Cx43 and Cx45 in
individual gap junctions in intact sections in which cell and tissue architecture were preserved. Immunolabeling of membrane
fractions enriched in gap junctions allowed us to quantify the
relative abundance of Cx43 and Cx45 in these preparations, and
biochemical studies confirmed co-immunoprecipitation of Cx43
and Cx45. In addition, based on quantitative immunoblotting, we
report that the magnitude of Cx43 expression in native ventricular myocardium is ~200 fmol/μg protein, and that Cx43 is ~300
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connexin remodeling in heteromeric gap junctions in health and
disease are incompletely understood. Post-translational modification, specifically phosphorylation, is known to regulate connexin
function and turnover. Phosphorylation of Cx45 has been shown
to stabilize Cx45,49 and to increase or decrease junctional conductance.61 However, little is known about the signaling pathways that
may be involved in phosphorylation of Cx45. Our data (Fig. 6 and
Figs. S6–S10 and Tables S5–S9) are the first to identify, by mass
spectrometry, residues phosphorylated by the multifunctional
protein kinase, CaMKII. Importantly, activation of CaMKII has
been shown to play a role in development of cardiac hypertrophy,
heart failure, myocardial ischemia and infarction.62-66 Several of
the residues phosphorylated by CaMKII were also phosphorylated
by CK1 (Figs. S11–S14 and Tables S10–S13). Future studies will
be required to determine whether CaMKII or CK1 phosphorylates
Cx45 in vivo and whether this phosphorylation is altered in cardiac
disease states to an extent that can influence cell-to-cell electrical
coupling and propagation of action potentials.
Limitations of the study. Although our data indicate that
Cx45 and Cx43 coexist in native ventricular gap junctions in the
relative proportions reported, our data do not allow us to distinguish between heteromeric and heterotypic channels. Based
on the large sizes of the gap junctions identified and quantified
in the present study, we suggest that they likely originated from
myocytes; however, we cannot rule out the possibility that at least
a fraction of the observed Cx45 signal may be attributed to other
cell types. Nor have we assessed the relative contribution of Cx45
and Cx43 to gap junction intercellular communication in ventricular myocytes. Furthermore, we have not yet determined the
physiological relevance of phosphorylation of Cx45 at the specific residues reported in this study, and whether phosphorylation
may regulate assembly or function of heteromeric gap junction
channels in vivo. Our data show that global measures of activation and conduction are not altered in Cx45OE hearts; thus,
we have yet to establish a mechanism for increased arrhythmia
susceptibility in Cx45OEs. The role of Cx45 in the proximal or
distal conduction system has not been investigated in sufficient
detail to know whether alterations in the expression level of Cx45
alone, or superimposed on a background of remodeled Cx43 in
diseased hearts, may be pathophysiologically relevant in mice or
in man. Finally, although it appears that an 85% reduction in
Cx45 in Cre +;Cx45fl/fl mice has modest effects on viability and
cardiac function, the Cre-lox transgenic mouse produced in the
present study did not result in total ablation of Cx45 (Figs. 4
and 5). There are two major hypotheses that may explain the
selection of surviving Cre +;Cx45fl/fl mice. First, expression of the
α-MHC promoter may be delayed (even by only one to a few
hours) in those mice that survive, such that deletion of Cx45 may
be delayed until after the time when its expression is essential for
development and viability. Survival of viable lines from individual founders suggests that delayed expression of the α-MHC promoter may be heritable (perhaps due to epigenetic effects), and
thus persists in subsequent generations. Alternatively, survival
of Cre +;Cx45fl/fl mice may reflect only partial ablation of Cx45,
whereby either a threshold level of Cx45 or a certain number of
Cx45-expressing cells is sufficient for survival.

Materials and Methods
Animals were handled in accordance with the NIH Guide for the
Care and Use of Laboratory Animals. The Washington University
Animal Studies Committee approved all protocols used in the
present study.
Cx45 transgenic mice. Cx45 overexpressing mice. Wild-type
(WT) and transgenic mice (C57BL6 strain) with cardiac-selective overexpression of Cx45 (Cx45OEs) were maintained in a
standard barrier facility. Genotyping and characterization of
these mice have been reported previously in reference 20.
Cx45 knockout mice. Embryos with genetic ablation of Cx45
were obtained after timed matings (10.5 days after visualization
of a vaginal plug) of Cx45 +/- mice.13 Uteruses were removed from
anesthetized mice. The yolk sac was used for PCR genotyping of
each individual embryo according to previously published protocols.37 Embryos were homogenized separately for individual
immunoblot analysis.
Cardiac Cx45-deficient mice. Cx45 floxed mice37 were bred
with α-myosin heavy chain (MHC)-Cre + mice38 to create cardiac-restricted ablation of Cx45. Two polymerase chain reactions
(PCR) were run for each sample of DNA using the following
primers to assess for presence of Cx45 floxed alleles:
I3Frev 5'-CTC TAG GAA CAC TGT AAC CTG AGA TGT
CCC-3'
I5FCfor 5'-GGA TTA AAG GCA TGT GTC ACC ACT
CTT GGC-3'
IE3rev 5'-AAG AAC GGC CAC AAC TCT GGT AAC AGG
AAG-3'
and the following primers to assess for presence of the Cre
recombinase gene:
MHC-Cre, forward 5'-ATG ACA GAC AGA TCC CTC
CTA TCT CC-3'
MHC-Cre, reverse 5'-CTC ATC ACT CGT TGC ATC
GAC-3'
Results from mice (FVB strain) of the following three genotypes
were pooled and used as controls for the cardiac Cx45-deficient
(Cre+;Cx45fl/fl) mice: Cre-;Cx45 +/+, Cre+;Cx45fl/+, Cre-;Cx45fl/fl.
Cx40 knockin Cx45 atria. Atrial tissue samples from Cx40
knockin Cx45 mice (Cx40KICx45/KICx45) 39 were obtained from Dr.
Patrick Jay with the generous permission of Dr. Daniel Gros.
These atrial samples which lack expression of Cx40 and exhibit
expression of Cx45 (knocked into the Cx40 locus) served as negative controls for Cx40 expression and positive controls for Cx45
expression.
Gap junction-enriched membrane preparations. Gap junction-enriched membrane fractions were prepared using a procedure published by Kensler and Goodenough40 using sucrose
density centrifugation as described in detail in the Supplemental
Content. The final yield of the gap junction-enriched fraction
was 3–9 μg protein per g of heart (wet weight).
Quantitative immunoblot analysis. Six His-Cx45 carboxylterminal (CT) and glutathione S-transferase (GST)-Cx43 CT
fusion protein constructs were grown and purified as described in
detail in the Supplemental Content. Ventricular homogenates,
six His-Cx45 CT fusion protein and GST-Cx43 CT fusion
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protein were each run in different lanes. Three separate Cx45
CT and three separate Cx43 CT fusion protein preparations were
used in the quantitative immunoblots reported here (Fig. S1).
Ventricular homogenates from a total of 16 hearts were run
on nine separate gels as described in the Supplemental Content
for quantitative immunoblot analysis. Standard fusion protein
curves were calculated in Excel and the ng of connexin protein
per 15 μg protein loaded in each lane were converted to fmol/μg
of total protein.
Immunoprecipitations. We performed co-immunoprecipitation experiments on murine ventricles that were flash frozen,
pulverized, homogenized and lysed as described in detail in the
Supplemental Content using monoclonal anti-Cx45 or antiCx43 antibody bound to protein G sepharose. A nonspecific
IgG1 was used as a negative control.
Immunogold electron microscopy. Ventricular tissue samples, cut with a vibratome, and isolated gap junction-enriched
membrane preparations were stained using a pre-embedding procedure published previously in references 41 and 42 as described
in the Supplemental Content.
Immunostaining and confocal analysis. Ten-μm frozen sections were incubated in rabbit anti-Cx45, rabbit anti-Cx43 or goat
anti-Cx40 antibodies and analyzed on a Zeiss LSM-510 META
confocal microscope as described in detail in the Supplemental
Content. A total of five Cre +;Cx45fl/fl and eight control hearts were
stained in four experiments. Adjacent tissue sections were stained
with anti-Cx45, anti-Cx43, anti-Cx40 and secondary (alone) antibodies for each experiment. Confocal images for a given antibody
and experiment were acquired on the same day with identical
confocal microscope settings. An investigator blinded to genotype
quantified immunoreactive signal using ImageJ software. Gap
junction staining was defined as five or more contiguous pixels.
Anti-Cx45 polyclonal antibody production. The same six
His-Cx45 CT fusion protein used in the quantitative immunoblots was used as antigen to immunize rabbits for production
of anti-Cx45 antiserum at Pocono Rabbit Farm & Laboratory;
antiserum was affinity purified and characterized as described in
detail in the Supplemental Content (Fig. S2).
In vitro electrophysiology studies of cardiac Cx45 transgenic mice. C57BL6 WT (n = 6) and Cx45OEs (n = 4) were
anesthetized with Avertin (0.1 mg/kg) followed by removal
and retrograde perfusion of hearts via the aorta at 25°C43 for in
vitro electrophysiology studies and optical mapping as described
in detail in the Supplemental Content. Inhomogeneity indices were calculated as described by Lammers et al.44 and in the
Supplemental Content.
A total of 11 FVB controls and four cardiac Cx45-deficient
Cre +;Cx45fl/fl mice were subjected to limited electrophysiological testing in vitro as described in the Supplemental Content.
Surface ECGs were recorded from nine mice (n = 5 controls
and n = 4 Cx45-deficient). Optical maps were obtained from
five mice (n = 3 controls and n = 2 Cx45-deficient). Activation
times were measured in 10 mice (n = 8 controls and n = 2
Cx45-deficient).
High-resolution mass spectrometric identification of Cx45
phosphorylation sites. Cx45 CT fusion protein was subjected to

in vitro phosphorylation using either Ca 2+/calmodulin‑dependent
kinase II (CaMKII, New England Biolabs) or casein kinase 1
(CK1, New England Biolabs) per the manufacturer’s instructions, and subjected to tandem mass spectrometry using a
Thermo LTQ XL Orbitrap (Thermo Fisher, San Jose, CA) as
described previously in reference 45.
Statistical analysis. All values are expressed as mean ± SD.
Two group comparisons were made using Student’s t-test for
grouped data. A value of p < 0.05 was considered significant.
Conclusions
The data presented here using a newly derived, fully characterized polyclonal anti-Cx45 antibody corroborates previous reports
of expression of the minor ventricular connexin, Cx45, by working ventricular myocytes.13,16-19,30-33 We have determined that
the levels of Cx45 are 0.3% of those of Cx43, and that cardiacrestricted genetic downregulation or overexpression of Cx45
does not result in any notable deficits in electrical conduction
throughout the heart under disease-free conditions. It is possible
that downregulation of Cx43 with concomitant upregulation of
Cx45 could shift the relative stoichiometry of these two connexins within heteromeric gap junctions in remodeled ischemic or
failing hearts. Finally, the role of CaMKII in regulating cardiac
Cx45 under both normal and pathophysiologic conditions merits
further investigation.
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